MIT Biotechnology Group

IDEATION 2019, Apr 22, 6-9 PM

Interested in learning about how to navigate resources for biotech entrepreneurship?
Looking to work on a startup but don’t yet have an idea you’re passionate about?
Want to hear and potentially join some of this year’s exciting early stage biotech teams out of Harvard and MIT?

V25 Figure 2

Join us at Ideation 2019, hosted by the MIT Biotech Group and the Harvard Biotech Club.
Get tickets HERE through 4/21 or until sold out. Learn more at our website.

When: April 22nd at 6 pm
Where: 32-123 (32 Vassar Street, Cambridge MA 02139)

Event Description & Format
Ideation is an annual event during which the Harvard and MIT communities come together to discuss commercializing science and the plethora of funding and development groups dedicated to biotech. Open to anyone in and beyond Boston, attendees will hear from an experienced executive and educator in biotechnology, 2 successful and established student-based teams out of Harvard and MIT, and a series of 2-minute pitches from selected newly formed teams looking to recruit members and share their vision.

Immediately following the event content, at 7:45pm, there will be a networking session with food provided during which students can learn about biotech startup resources from representatives of our partnering organizations, meet pitching teams, and discuss potential future involvement or collaboration.

Ideation 2019 Partners
Martin Trust Center (lead sponsor), Harvard iLabs, Harvard LifeLab, MIT 100k, Harvard OTD, MIT TLO, MIT Venture Mentoring Service, NSF I-Corps at MIT, Sloan Healthcare Club, HBS Healthcare Club, the Harvard Undergraduate Biotechnology Association, MassBio, LabCentral, Alexandria LaunchLabs, and the MIT Engine

Ideation 2019 Speakers
Dr. Robert S. Langer is the David H. Koch Institute Professor at MIT and is considered “one of history’s most prolific inventors in medicine”. He has authored more than 1,400 articles and has over 1,300 issued and pending patents worldwide. Dr. Langer is the most cited engineer in history and has licensed his patents to over 350 pharmaceutical, chemical, biotechnology and medical device companies. Dr. Langer has received numerous major awards and medals including the United States Nation Medal of Science (2006), the United States Nation Medal of Technology and Innovation (2011) the Lemelson-MIT Prize (the world’s largest prize for invention) (1998) and he was recently named one of five U.S. Science Envoys for 2018. As a Science Envoy for Innovation, Dr. Langer will be focusing on novel approaches in biomaterials, drug delivery systems, nanotechnology, tissue engineering and the U.S approach to research commercialization

Armon Sharei, PhD is the founder and CEO of SQZ Biotech. SQZ biotech uses a proprietary CellSqueeze platform that emerged from Dr. Sharei’s work in the Langer and Jensen labs to develop a new generation of unique cell therapies. Armon was awarded the 2017 Young Innovator award and has been named to Forbes 30 Under 30 and Endpoints 40 under 40. SQZ won the $100,000 grand prize in the 2014 MassChallenge and has a billion dollar deal with Roche.

Eric Kelsic, PhD is the Cofounder and CEO of Dyno Therapeutics, which emerged from his work in the Church Lab. Dyno combines next-generation DNA synthesis of millions of AAV capsids with high-throughput sequencing and machine learning to create novel AAV vectors that enable the safe, efficient and targeted in vivo delivery of gene therapies. Dr. Kelsic will speak to Dyno’s strategy from establishing a strong executive team to securing VC backing.

If you have questions about Ideation, email us at mitharvardpitch@gmail.com.

Leave a Reply